Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Rivan raises £25m for Europe's biggest SNG plant

3 min read
16:30UTC

A Wiltshire startup pulled IQ Capital, Plural, and a European founder-angel trio onto its cap table to build synthetic gas at 15MW scale.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

Rivan's angel syndicate shows UK cleantech can scale outside state programmes if European operator capital backs it.

Rivan, founded by Harvey Hodd, raised £25m on 20 April 2026 to build Project Steadfast, a 15MW synthetic natural gas plant in Wiltshire. IQ Capital led with Plural; angel investors included Matt Clifford of Entrepreneur First, Thomas Wolf of Hugging Face, and Markus Villig of Bolt. Total raised now stands at $46m, and the company has a commercial offtake partnership with Wales & West Utilities.

Synthetic natural gas (SNG) is methane manufactured from captured CO2 and green hydrogen rather than extracted from a well. The output is molecularly identical to fossil gas, meaning it runs on existing pipeline infrastructure, boilers, and industrial burners without replacement capex; that substitutability is the commercial proposition. Project Steadfast's 15MW scale makes it Europe's largest SNG facility and the first to inject SNG directly into the UK gas grid.

Four backers, four distinct European pedigrees. IQ Capital is a Cambridge deep-tech VC; Plural is a European fund founded by the Skype and Wise operators. The three angels each founded a category-defining European company: Clifford's Entrepreneur First runs the continent's largest talent-first accelerator; Wolf co-founded the AI platform Hugging Face; Villig built Bolt into Europe's largest ride-hailing operator by vehicle count. A cleantech startup pulling that mix of operator angels onto a grid-injection project is a signal about where European founder capital is migrating, and it is not toward the same US-dominated climate funds that dominated the last boom.

The cleantech vertical sits outside the UK's main targeted state-capital corridors. SAIU targets AI, ProQure targets quantum, LSIMF targets life sciences, and there is no equivalent multi-billion programme specifically for synthetic fuels. Rivan demonstrates that UK cleantech can still assemble material capital through VC plus founder-angel syndication at single-digit-£10m ticket sizes, though the ceiling on that mechanism is £25m, not £250m.

Deep Analysis

In plain English

Synthetic natural gas (SNG) is made by converting hydrogen into a gas that works exactly like the natural gas already in UK homes and factories. Rivan is building Europe's biggest factory for this process in Wiltshire, and it will be the first time this kind of gas has been pumped directly into the UK gas grid. The advantage is that industries using gas-powered furnaces or boilers do not need to change their equipment; they just switch to a cleaner version of the fuel they already use. The investors include the founders of Hugging Face and Bolt, two very well-known European tech companies, which is unusual for what is essentially an energy infrastructure project.

Deep Analysis
Root Causes

Natural gas demand from industries that cannot electrify; glass furnaces, ceramics, food processing, steel reheating; is projected to persist at 30-40% of current UK industrial gas consumption through 2040 per National Grid ESO's Future Energy Scenarios (2025); SNG from green hydrogen is the only currently technically viable substitute that does not require those industries to refit their combustion equipment.

The UK's hydrogen strategy (2021) allocated £240m to hydrogen production but did not create a mandatory blending target for the gas grid, leaving SNG injection commercially marginal without a voluntary green premium; Rivan's angel syndicate; Clifford, Wolf, Villig; reflects the project's dependence on conviction capital rather than policy-backed debt.

What could happen next?
  • Consequence

    Project Steadfast will be the first commercial test of whether the UK gas grid's metering infrastructure can issue Renewable Gas Guarantees of Origin for SNG at MW scale; if Wales and West Utilities cannot certify the injection, the project's revenue model collapses to commodity gas pricing and Rivan will need a Contracts for Difference application to reach Series B.

  • Opportunity

    A successful 15MW SNG injection at Wiltshire gives Rivan a replicable template for sites near industrial gas clusters; Teesside, Humber, Grangemouth; where hard-to-abate manufacturing demand is concentrated and grid injection capacity already exists, unlocking a pipeline of 10-15 further sites without new grid infrastructure.

Sources:City AM
Mentions:Rivan →Plural →Matt Clifford →Thomas Wolf →Markus Villig →Entrepreneur First →Hugging Face →Bolt →Cambridge →ProQure →Project Steadfast →Harvey Hodd →Wiltshire →Sovereign AI Unit →Venture Capital Trusts →Life Sciences Innovative Manufacturing Fund →National Grid →IQ Capital →
First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

City AM· 22 Apr 2026
Read original →
Causes and effects
This Event
Rivan raises £25m for Europe's biggest SNG plant
Rivan's syndicate pairs UK deep-tech VC with three European category-defining founders, a pattern that routes scale-up validation to UK cleantech without VCT dependency.
Led to
Nyobolt hits £1bn on Symbotic-led Series C
IQ Capital's participation in Nyobolt Series C continues its pattern of anchoring Cambridge deeptech spinout rounds alongside strategics, as it did in the Rivan raise (ID:2702).
Occurred 6 May 2026
Read story →
Mykor's £4m grows panels from mushrooms
Rivan's £25m cleantech raise in Wiltshire (ID:2702) showed regional, non-Golden-Triangle deeptech capital continues to flow outside AI; Mykor's £4m Bristol raise echoes that pattern.
Occurred 27 May 2026
Read story →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.